نتایج جستجو برای: chronic spontaneous urticaria csu

تعداد نتایج: 608890  

Journal: :Kathmandu University Medical Journal 2022

Background Chronic Spontaneous Urticaria is considered to be an autoimmune phenomenon in half of the total cases. Autologous serum skin test a simple screening for presence auto-antibodies chronic urticaria. Significant impairment quality life have been observed autologous positive There are limited literatures on spontaneous urticaria, and associated Dermatology Life Quality Index Nepal till d...

Journal: :Journal of Allergy and Clinical Immunology 2018

2016
Ana M. Gimenéz-Arnau Sheldon Spector Evgeniya Antonova Benjamin Trzaskoma Karin Rosén Theodore A. Omachi Donald Stull Maria-Magdalena Balp Thomas Murphy

BACKGROUND Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. METHODS We examined the effect of omalizumab on sleep-related outcomes during 3-6 months omalizumab or placebo treatment and a 16-week follow-up period within three Phase III double-blind randomized placebo-controlled pivotal trials in CIU/CSU: ASTERIA I, ASTERIA II, and GLACIAL. Sleep qu...

2017
Magdalena Czarnecka-Operacz Anna Sadowska-Przytocka Dorota Jenerowicz Anna Szeliga Zygmunt Adamski Katarzyna Łącka

Introduction Chronic urticaria (CU) is a skin disease caused by autoantibodies against high affinity immunoglobulin E (IgE) receptor and against IgE. It is characterized by hives, erythematous wheals and redness present minimum twice a week for at least 6 weeks. It is observed that there is a strong association between CU and autoimmune diseases, such as autoimmune thyroiditis (AT). Aim To ve...

Journal: :Archives of disease in childhood. Education and practice edition 2015
Roisin Fitzsimons Lauri-Ann van der Poel William Thornhill George du Toit Neil Shah Helen A Brough

This review provides an overview of the use of antihistamines in children. We discuss types of histamine receptors and their mechanism of action, absorption, onset and duration of action of first-generation and second-generation H(1)-antihistamines, as well as elimination of H(1)-antihistamines which has important implications for dosing in children. The rationale for the use of H(1)-antihistam...

Journal: :The Egyptian journal of immunology 2014
Asmaa S M Abdel-Rehim Dina S Sheha Nesrine A Mohamed

Vitamin D has an important role in the immune system. Decreased serum vitamin D level is known to be associated with autoimmune and atopic diseases. This study aimed to assess vitamin D status in patients with chronic spontaneous urticaria (CSU) and its relation with severity of the disease. This case-control study was conducted on 22 patients and 20 age and sex matched controls. Patients were ...

2009
Bettina Wedi Ulrike Raap Dorothea Wieczorek Alexander Kapp

Urticaria is a group of diseases that share a distinct skin reaction pattern. Triggering of urticaria by infections has been discussed for many years but the exact role and pathogenesis of mast cell activation by infectious processes is unclear. In spontaneous acute urticaria there is no doubt for a causal relationship to infections and all chronic urticaria must have started as acute. Whereas ...

2015
Misbah Nasheela Ghazanfar Simon Francis Thomsen

Chronic spontaneous urticaria is an itching skin disease characterised by wheals, angioedema, or both present for more than six weeks. Omalizumab is a humanized anti-IgE monoclonal antibody recently approved for treatment of chronic urticaria. Several randomised controlled trials have investigated the safety, tolerability, and efficacy of omalizumab for chronic urticaria. The safety of omalizum...

Journal: :Journal of Investigative Dermatology 2022

Chronic spontaneous urticaria (CSU) is defined by the presence of recurrent hives, associated in over 60% cases with angioedema, lasting for more than 6 weeks, due to unknown trigger. It affects around 1% adult population and has a negative impact on patients’ quality life, interfering their daily activities work productivity. Omalizumab an anti-IgE monoclonal antibody, first biologic agent app...

Journal: :JAMA dermatology 2014
Martin Metz Tatevik Ohanyan Martin K Church Marcus Maurer

IMPORTANCE Omalizumab has emerged as a novel and effective treatment option for patients with antihistamine-resistant chronic urticaria. It is unclear whether patients with recurrent urticaria symptoms after discontinuation of omalizumab treatment can benefit from retreatment. OBJECTIVE To assess the response of patients with chronic urticaria who receive omalizumab retreatment. DESIGN, SET...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید